How much does ‘shoulder season’ travel save? We crunch the numbers in 5 top spots
As travelers shift when they travel, off-season rates are changing. Deals can still be found in Japan, the Maldives and Rome, but there are fewer...
Markets seen on edge after drone attack kills U.S. troops, escalates Mideast crisis
A drone attack that killed three U.S. service members in northern Jordan, blamed by the White House on Iran-backed militants, marks a major escalation of...
Stock-market rally faces Fed, tech earnings and jobs data in make-or-break week
The stock-market soon resumed its record run in 2024. This week presents some big hurdles.
Data Update 4 for 2024: Danger and Opportunity – Bringing Risk into the Equation!
In my last data updates for this year, I looked first at how equity markets rebounded in 2023, driven by a stronger-than-expected economy and inflation...
The busiest and most crucial week for fourth-quarter earnings is here. These five companies will do the heavy lifting.
The heaviest stretch of the fourth-quarter earnings storm hits this week, with 106 companies set to report results.
Mark Cuban: Here’s the moment I knew I wouldn’t succeed in corporate America
Billionaire Mark Cuban's early-career experiences at a bank and a software retailer taught him that entrepreneurship was more his style than corporate America.
Bitbot picks momentum as Avalanche leads altcoin recovery
Avalanche has spiked double-digits amid new momentum forecast for rally to $100. BITBOT could be the pick of presale tokens with its investment potential buoyed...
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
Fast-approaching patent expirations will take a bite out of revenues and put the industry's top players in the hot seat over the next few years.